Open data 5 years on: a case series of 12 freedom of information requests for regulatory data to the European Medicines Agency
Citation
Doshi P, Jefferson T. (2016). Open data 5 years on: a case series of 12 freedom of information requests for regulatory data to the European Medicines Agency. Trials, 17:78. DOI: 10.1186/s13063-016-1194-7.Keyword
research transparencyclinical study reports
access to documents
regulatory science
reporting bias
publication bias
evidence synthesis
EMA
CSR
European Medicines Agency
Freedom of information
Cochrane Collaboration
Systematic reviews (Medical research)
Clinical Trials as Topic
Identifier to cite or link to this item
http://hdl.handle.net/10713/6663ae974a485f413a2113503eed53cd6c53
10.1186/s13063-016-1194-7
Scopus Count
Collections
Related articles
- Access to regulatory data from the European Medicines Agency: the times they are a-changing.
- Authors: Wieseler B, McGauran N, Kerekes MF, Kaiser T
- Issue date: 2012 Oct 30
- Clinical study reports published by the European Medicines Agency 2016-2018: a cross-sectional analysis.
- Authors: Byrne D, Prendergast C, Fahey T, Moriarty F
- Issue date: 2023 May 15
- Clinical trial transparency: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved recently in Europe.
- Authors: Rawal B, Deane BR
- Issue date: 2014 Mar
- Secret safety warnings on medicines: A case study of information access requests.
- Authors: Torka M, Mintzes B, Bhasale A, Fabbri A, Perry L, Lexchin J
- Issue date: 2019 Apr
- European Federation of Statisticians in the Pharmaceutical Industry's position on access to clinical trial data.
- Authors: Fletcher C, Driessen S, Burger HU, Gerlinger C, Biesheuvel E, EFSPI
- Issue date: 2013 Nov-Dec